Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Gutfraind

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Emerging Infectious Diseases|January 28, 2015
Optimizing distribution of pandemic influenza antiviral drugsBismark Singh, Hsin-Chan Huang, David P Morton, et al.
Plos One|March 10, 2022
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan ChicagoEric Tatara, Alexander Gutfraind, Nicholson T Collier, et al.
PNAS Nexus|January 8, 2025
Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testingMary-Ellen Mackesy-Amiti, Alexander Gutfraind, Eric Tatara, et al.
Science Translational Medicine|July 13, 2018
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug usersMarian Major, Alexander Gutfraind, Louis Shekhtman, et al.
Plos Neglected Tropical Diseases|November 30, 2018
Integrating evidence, models and maps to enhance Chagas disease vector surveillanceAlexander Gutfraind, Jennifer K Peterson, Erica Billig Rose, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Emerging Infectious Diseases|January 28, 2015
Optimizing distribution of pandemic influenza antiviral drugsBismark Singh, Hsin-Chan Huang, David P Morton, et al.
Plos One|March 10, 2022
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan ChicagoEric Tatara, Alexander Gutfraind, Nicholson T Collier, et al.
PNAS Nexus|January 8, 2025
Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testingMary-Ellen Mackesy-Amiti, Alexander Gutfraind, Eric Tatara, et al.
Science Translational Medicine|July 13, 2018
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug usersMarian Major, Alexander Gutfraind, Louis Shekhtman, et al.
Plos Neglected Tropical Diseases|November 30, 2018
Integrating evidence, models and maps to enhance Chagas disease vector surveillanceAlexander Gutfraind, Jennifer K Peterson, Erica Billig Rose, et al.
Pageof 3